What is Nektar Therapeutics's total equity?

Nektar Therapeutics (NKTR) reported total equity of $576.22M in Q1 2026.

How has Nektar Therapeutics's total equity changed year-over-year?

Nektar Therapeutics's total equity increased by 4094.3% year-over-year, from $13.74M to $576.22M.

What is the long-term trend for Nektar Therapeutics's total equity?

Over 5 years (2020 to 2025), Nektar Therapeutics's total equity has grown at a -39.2% compound annual growth rate (CAGR), from $1.08B to $89.83M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Nektar Therapeutics NKTR Total Equity

Total Equity at other companies

AmgenAMGN

$9.19B+48.1%

Regeneron PharmaceuticalsREGN

$31.42B+6.9%

ImmunityBio, Inc.IBRX

-$870.01M-47.1%

ImmunomeIMNM

$588.69M+91.7%

Vera TherapeuticsVERA

$499.7M-6.6%

Iovance Biotherapeutics, Inc.IOVA

$721.75M-6.0%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's total equity?: Nektar Therapeutics (NKTR) reported total equity of $576.22M in Q1 2026.
How has Nektar Therapeutics's total equity changed year-over-year?: Nektar Therapeutics's total equity increased by 4094.3% year-over-year, from $13.74M to $576.22M.
What is the long-term trend for Nektar Therapeutics's total equity?: Over 5 years (2020 to 2025), Nektar Therapeutics's total equity has grown at a -39.2% compound annual growth rate (CAGR), from $1.08B to $89.83M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.